Method development for the quantitative determination of captopril from Caco-2 cell monolayers by using LC-MS/MS.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 61, doi. 10.3897/pharmacia.68.e52077
- By:
- Publication type:
- Article
Works matching IS 04280296 AND DT 2021 AND VI 68 AND IP 1
Results: 22
1
2
Quinolone resistance (qnrA) gene in isolates of Escherichia coli collected from the Al-Hillah River in Babylon Province, Iraq.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 1, doi. 10.3897/pharmacia.68.e57819
- By:
- Publication type:
- Article
3
COVID-19 – the challenge to treat a disease and not a positive RT-PCR test.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 155, doi. 10.3897/pharmacia.68.e61906
- By:
- Publication type:
- Article
4
In vitro effects of synthetic muscimol and an extract from Amanita muscaria on human recombinant MAOB enzyme.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 147, doi. 10.3897/pharmacia.68.e60705
- By:
- Publication type:
- Article
5
Liquid chromatography – high resolution mass spectrometry screening of Astragalus hamosus and Astragalus corniculatus.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 135, doi. 10.3897/pharmacia.68.e60621
- By:
- Publication type:
- Article
6
Immunnostimulatory activity of Holothuria atra sea cucumber..
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 121, doi. 10.3897/pharmacia.68.e58820
- By:
- Publication type:
- Article
7
The synthesis of N-(4-aryl-thiazol-2-yl)-N¹ - (4,5,6,7-tetrahydro-3H-azepin-2-yl)-hydrazine hydrobromides and the cardioprotective activity of (4¹ -methoxyphenyl-thiazol-2-yl) derivative.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 141, doi. 10.3897/pharmacia.68.58788
- By:
- Publication type:
- Article
8
Method development and validation for the determination of residual solvents in quinabut API by using gas chromatography. Message 2.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 53, doi. 10.3897/pharmacia.68.e52119
- By:
- Publication type:
- Article
9
Opportunities of information communication technologies for providing pharmaceutical care in the COVID-19 pandemic.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 9, doi. 10.3897/pharmacia.68.e56987
- By:
- Publication type:
- Article
10
Analysis of carboxylic acids of Crambe cordifolia Steven .
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 15, doi. 10.3897/pharmacia.68.e56715
- By:
- Publication type:
- Article
11
Synthesis of new series of pyrimidine nucleoside derivatives bearing the acyl moieties as potential antimicrobial agents.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 23, doi. 10.3897/pharmacia.68.e56543
- By:
- Publication type:
- Article
12
Prevalence of use of permitted pharmacological substances for recovery among athletes.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 35, doi. 10.3897/pharmacia.68.e54581
- By:
- Publication type:
- Article
13
Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 43, doi. 10.3897/pharmacia.68.e53631
- By:
- Publication type:
- Article
14
Synthesis and antioxidant properties of some new 5-phenethyl-3-thio-1,2,4-triazoles.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 129, doi. 10.3897/pharmacia.68.e53320
- By:
- Publication type:
- Article
15
Development and validation of a fast and simple HPLC method for the simultaneous determination of bisoprolol and enalapril in dosage form.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 69, doi. 10.3897/pharmacia.68.e50919
- By:
- Publication type:
- Article
16
Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 79, doi. 10.3897/pharmacia.68.e50704
- By:
- Publication type:
- Article
17
Therapeutic guidelines in chronic low back pain.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 117, doi. 10.3897/pharmacia.68.e50297
- By:
- Publication type:
- Article
18
The study of the therapeutic effectiveness of the associated inactivated and subunit vaccines based on Candida albicans and Candida tropicalis fungi.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 89, doi. 10.3897/pharmacia.68.e49384
- By:
- Publication type:
- Article
19
Therapeutic guidelines for the treatment of cystic fibrosis.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 151, doi. 10.3897/pharmacia.68.49247
- By:
- Publication type:
- Article
20
Interactions between the cannabinoid and the serotonergic systems in modulation of pain perception.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 109, doi. 10.3897/pharmacia.68.e49219
- By:
- Publication type:
- Article
21
The investigation of antimicrobial and antifungal activity of some Artemisia L. species.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 93, doi. 10.3897/pharmacia.68.e47521
- By:
- Publication type:
- Article
22
Modelling and investigation of amoxicillin chemical interaction with mineral waters containing a significant amount of calcium and magnesium salts.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 1, p. 101, doi. 10.3897/pharmacia.68.e39573
- By:
- Publication type:
- Article